virus

(redirected from HTLV-III)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.
Related to HTLV-III: human T-lymphotropic virus type 1, human T-cell lymphotrophic virus
See: disease
References in periodicals archive ?
It was further stated that HTLV-III proteins had been found in 85% of sera from AIDS patients and that HTLV-III is related to HTLV-I and -II, retroviruses previously discovered by Gallo.
Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome.
report that they had inadvertently used a picture of a virus grown from material provided by Montagnier's laboratory -- thus, LAV-I -- as an illustration in their initial article describing the HTLV-III virus (SN: 4/28/84, p.
While the Frederick work firms up the virus's position in the lentivirus family, it won't help in naming the virus, which is variously called HTLV-III, LAV (for lymphadenopathy-AIDS virus) or ARV (for AIDS-related virus).
In culture, the HTLV-III virus doesn't change much, so many of the genetic changes in the virus probably occur when the viral DNA is transcribed into DNA in the body, says Gallo.
Incubation time after HTLV-III exposure can be as long as:
East Coasteres were calling it HTLV-III, for human T cell lymphotropic virus, though the L used to stand for leukemia.
Recent studies throughout the United States have shown that patients and their specimens do not transmit HTLV-III to health care workers.
The scientists looked for the presence of antibodies to HTLV-III, a putative cause of AIDS, and found it in 50 to 75 samples checked, suggesting, they say, "that the virus detected may have been a predecessor of HTLV-III or HTLV-III itself but existing in a population acclimated to its presence.
To date, the Food and Drug Administration has licensed five manufacturers to market kits detecting antibodies to HTLV-III.
When Robert Gallo nine months ago announced HTLV-III as the U.
Even before the ELISA test for antibodies to HTLV-III, the incidence of transfusion-associated AIDS reportedly fell from 1 in 100,000 to 1 in 1,000,000.